PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsbronchitis
MeSH D001991 - bronchitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012141:Respiratory tract infections
98 Companies
34 Drugs
$
Success rate
D008173:Obstructive lung diseases
56 Companies
9 Drugs
$
Success rate
D001982:Bronchial diseases
0 Companies
0 Drugs
Success rate
D001991: 
Bronchitis
167 Companies
46 Drugs
$
Success rate
D001988:Bronchiolitis
0 Companies
0 Drugs
Success rate
D029481:Chronic bronchitis
52 Companies
16 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAlbuterol, Ipratropium Albuterol Ipratropium  2007-12-31   
Cefaclor Cefaclor  1995-04-27   
Cefdinir Cefdinir  2007-05-04   
Clarithromycin Clarithromycin  2005-05-31   
Sulfamethoxazole, Trimethoprim Cotrim  1985-05-16   
Sulfamethoxazole, Trimethoprim Cotrim D.s  1985-03-18   
Ipratropium Ipratropium  2000-02-07   
Levofloxacin Levofloxacin  2011-06-20   
Moxifloxacin Moxifloxacin  2014-02-18   
Ofloxacin Ofloxacin  2003-09-02   
Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  1991-10-31   
Trimethoprim Trimethoprim  1987-06-18   
Glenmark PharmaceuticalsLevofloxacin Levofloxacin  2011-06-20   
Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2010-12-22   
Acetylcysteine Acetylcysteine  2022-02-03   
MylanClarithromycin Clarithromycin  2005-03-11   
Albuterol, Ipratropium Duoneb  2001-03-21   
Ipratropium Ipratropium  1997-01-10   
Levofloxacin Levofloxacin  2011-06-20   
Moxifloxacin Moxifloxacin  2017-05-05   
Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2017-08-30   
NATCO PharmaLevofloxacin Levofloxacin  2011-06-20   
Moxifloxacin Moxifloxacin  2015-08-31   
Johnson & JohnsonOfloxacin Floxin  1990-12-28   
Levofloxacin Levaquin  1996-12-20   
PerrigoGuaifenesin Guaifenesin  2011-11-23   
Dextromethorphan, Guaifenesin Guaifenesin Dextromethorphan  2018-03-05   
Pseudoephedrine, Guaifenesin Guaifenesin Pseudoephedrine  2022-02-01   
RocheTrimethoprim Trimpex  1982-01-01   
CiplaAlbuterol, Ipratropium Albuterol Ipratropium  2007-12-31   
Lupin ResearchCefdinir Cefdinir  2006-05-31   
Clarithromycin Clarithromycin  2015-09-15   
Levofloxacin Levofloxacin  2011-06-20   
Moxifloxacin Moxifloxacin  2014-09-04   
Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2021-01-05   
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
100%
2/2
Phase 3
78%
32/41
Approved: 27Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Albuterol,
Moxifloxacin,
Cefdinir,
Cefprozil,
Clarithromycin,
Ipratropium,
Ipratropium bromide,
Sodium chloride,
Levosalbutamol
Mylan
Albuterol,
Clarithromycin,
Ipratropium,
Ipratropium bromide,
Moxifloxacin
Johnson & Johnson
Levofloxacin,
Ofloxacin,
Theophylline,
Clavulanic acid,
Clavulin,
Trinessa,
Fluoroquinolone,
Clavamox,
Cotrimoxazole
Perrigo
Dextromethorphan,
Guaifenesin,
Pseudoephedrine
Roche
Trimethoprim,
Tiratricol,
Cotrimoxazole
Cipla
Albuterol
Sandoz
Cefprozil,
Clarithromycin
Boehringer Ingelheim
Albuterol,
Ipratropium,
Ipratropium bromide,
Ademetionine,
Sodium chloride
Harrow
Moxifloxacin
1
2
3
4
5
6
...
12
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use